Trial Profile
A phase 2, randomized, multi-center, double-blind, placebo-controlled, parallel-group, dose-range-finding study of the safety and efficacy of orally administered MD-0727 in patients with primary hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs MD 0727 (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 03 Mar 2007 New trial record.